BARBA, MARTA

BARBA, MARTA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.029 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Impact of postoperative cardiovascular complications on 30-day mortality after major abdominal surgery: an international prospective cohort study 01 - Articolo su rivista 2024 Fruscio R.Ciulli C.Braga M.Romano F.Garancini M.Carissimi F.Vico E.Negri S.Corti J.Tamini N.Cigagna L.Giordano R.Davolio A.Trezzi G.Grassi T.Procaccianti C.Nespoli L. C.Pitoni L.Fogliati A.Cordaro G.Passoni P.Fantauzzi M.Villa S.Scotti M. A.Di Lucca G. M.Benedetti F.Masseria P.Frigerio M.Barba M.Re I.Ceresoli M.Ferraina F.Adjei Antwi S. K.Fumagalli C.Di Martino G.Di Meo M. L. +
Prevalence and severity of sexual disorders in the third trimester of pregnancy 01 - Articolo su rivista 2024 Frigerio, MatteoBarba, MartaPalmieri, StefaniaManodoro, StefanoVergani, Patrizia +
Clinical, ultrasonographic, and functional outcomes after obstetric anal sphincter injury primary repair: A single-center experience 01 - Articolo su rivista 2023 Cola A.Vergani P.Barba M. +
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause 01 - Articolo su rivista 2023 Barba M.De Vicari D.Costa C.Volontè S.Fruscio R.Frigerio M. +
Prevalence and severity of bowel disorders in in the third trimester of pregnancy 01 - Articolo su rivista 2023 Barba M.Palmieri S.Manodoro S.Vergani P. +
Response: Risk factors for obstetric anal sphincter injury recurrence: A systematic review and meta-analysis 01 - Articolo su rivista 2023 Barba M.Bernasconi D. P.Manodoro S.Frigerio M.
Risk factors for obstetric anal sphincter injury recurrence: A systematic review and meta-analysis 01 - Articolo su rivista 2022 Barba M.Bernasconi D. P.Manodoro S.Frigerio M.
Postpartum urinary retention: Absolute risk prediction model 01 - Articolo su rivista 2021 Barba M.Frigerio M.Manodoro S.Bernasconi D. P.Cola A.Palmieri S.Fumagalli S.Vergani P.
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 01 - Articolo su rivista 2020 Barba M.Cassano A.Cazzaniga M. +